Search results
Results from the WOW.Com Content Network
NEIMETH International Pharmaceuticals PLC is a publicly listed pharmaceutical company founded in 1997 and headquartered in Lagos. It was established by a former managing director of Pfizer Products of Nigeria to acquire some of the trading assets of Pfizer International in Nigeria.
Nigeria is a federal republic in West Africa, bordering Benin in the west, Chad and Cameroon in the east, and Niger in the north. As of 2015 Nigeria has the world's 20th largest economy, worth more than $500 billion and $1 trillion in terms of nominal GDP and purchasing power parity respectively.
The pharmaceutical industry in Nigeria is oligopoly, being a multi-product industry. ... List of pharmaceutical companies operating in Nigeria:
In August 2021, African Export-Import Bank awarded $400,000 grants to NIPRD to boost local production of active pharmaceutical ingredients. [6] In April 2022, the NIPRD signed a Memorandum of Understanding with the University of KwaZulu-Natal, South Africa, to improve the industry value chain for traditional medicine in Nigeria and Africa. [7]
Pages in category "Pharmaceutical companies of Nigeria" This category contains only the following page. This list may not reflect recent changes. N. Neimeth PLC
Company Industry Revenue (US$ millions) Profits (US$ millions) 1 Nigeria National Petroleum: Oil and gas 9,706 1,877 2 Nigeria Liquefied Natural Gas: Oil and gas 6,315 ... 3 MTN Nigeria: Telecommunications 3,514 536 4 Dangote Cement: Cement 2,699 721 5 Nigerian Petroleum Development: Oil and gas 2,686 219 6 Flour Mills of Nigeria: Agroindustry ...
Multinational companies based in Lagos (2 C, 16 P) Pages in category "Companies based in Lagos" The following 153 pages are in this category, out of 153 total.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.